MOATAZEDI DAVID 4
4 · Evolus, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Evolus, Inc.EOLS
MOATAZEDI DAVID
DirectorSee Remarks
Transactions
- Sale
Common Stock
2024-06-04$12.73/sh−140,214$1,784,686→ 533,349 total - Exercise/Conversion
Common Stock
2024-06-05$5.46/sh+155,278$847,818→ 688,627 total - Sale
Common Stock
2024-06-05$12.92/sh−155,278$2,006,456→ 533,349 total - Sale
Common Stock
2024-06-06$12.59/sh−175,940$2,214,486→ 533,349 total - Exercise/Conversion
Common Stock
2024-06-06$7.28/sh+175,940$1,280,843→ 709,289 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-06−175,940→ 1,006,079 totalExercise: $7.28Exp: 2028-05-06→ Common Stock (175,940 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-05−155,278→ 155,281 totalExercise: $5.46Exp: 2032-01-25→ Common Stock (155,278 underlying)
Footnotes (5)
- [F1]The shares were sold in multiple trades at prices ranging from $12.70 to $12.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The shares were sold in multiple trades at prices ranging from $12.77 to $13.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The shares were sold in multiple trades at prices ranging from $12.40 to $12.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
- [F5]The shares subject to the option vested in full over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.